How should TGA registration, reimbursement access and channel sales connect?

Author:Sonictec · 2026-09-14 Updated

Three questions to answer separately

Businesses entering Australia usually need to understand both authorization and who will buy and supply the product. Regulatory authorization, reimbursement or other payment arrangements, and commercial channels solve different problems. Plan them together, but verify each separately.

Regulatory access: confirm the product and pathway

For medical devices and IVDs, use intended purpose, classification and existing evidence to define Australian application and supply arrangements. Medicines and other products follow their own frameworks; one device pathway cannot cover every healthcare product.

Payment pathways: first assess product eligibility

The Prescribed List covers private health insurance benefits for certain medical devices and human tissue products, rather than all medical products. Confirm scope, evidence and application requirements before committing resources. TGA registration alone does not secure listing.

Source:Australian Department of Health: Prescribed List

Commercial channels: who buys, and why?

Channel strategy should reflect product value, target users, pricing, procurement and partners. A pharmacy or distribution model suitable for one product may not suit another. Clear positioning and commercial conditions improve outreach discussions.

Local delivery: plan inventory and distribution early

Inventory, batches, storage, transport, replenishment and after-sales arrangements affect delivery after channel entry. Match actual requirements to local resources, particularly for products with special conditions.

List authorization and procurement conditions separately

Start with actual buyers and ask what product information, training, delivery, after-sales and procurement materials they need. Regulatory access addresses supply conditions, while buyers make their own purchasing decisions. Record pending authorizations, unfinished preparation and prospective opportunities separately; a channel discussion is not a confirmed sale.

Before supply begins, confirm who maintains product information

Use consistent model, packaging and product descriptions across regulatory, sales, warehousing and partner teams, and agree update notifications. Define how inventory, returns and after-sales information reaches responsible parties, implementing these arrangements against product storage and authorization requirements.

Discussing commercial coordination with Sonictec

Start with the product, target customer type, current ARTG or application status, supply territories and support needed. Registration, Sponsor, channels and warehousing can be discussed separately. Resources, regions and delivery scope require project-specific confirmation; a public registration does not prove sales capability or procurement outcomes.

Connect each stage to the same project objective

Clarify current status, target customers, evidence needs and timing, then agree staged work with partners. Sonictec can discuss registration, Sponsor services, applicable reimbursement pathways, channels and Australian warehousing together.

Further reading

• When should you contact your Australian Sponsor about post-registration changes?
• What should you prepare before a TGA registration consultation?